GlassScriptPhysician profile
Meghan Larkin
NPI 1629403407
$1,753.99
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $597 · 2022: $1,157.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $485.75 | 2021-2022 | |
| Novo Nordisk INC | $139.67 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.03 | 2021-2022 | |
| Lilly USA, LLC | $101.52 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $85.55 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.16 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $66.40 | 2021-2022 | |
| Amgen INC. | $57.62 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $49.30 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.04 | 2022 | |
| Optinose US, INC. | $44.85 | 2022 | |
| Pfizer INC. | $44.51 | 2021 | |
| Janssen Pharmaceuticals, INC | $40.31 | 2021-2022 | |
| Eisai INC. | $33.09 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $29.16 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $28.97 | 2022 | |
| Neos Therapeutics, LP | $27.44 | 2022 | |
| Glaxosmithkline, LLC. | $24.75 | 2021 | |
| Therapeuticsmd, INC. | $21.50 | 2021 | |
| Upsher-Smith Laboratories LLC | $18.89 | 2021 | |
| Organon LLC | $18.38 | 2022 | |
| Exeltis, USA INC. | $17.83 | 2022 | |
| Boston Scientific Corporation | $17.49 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.45 | 2022 | |
| Bausch Health US, LLC | $14.30 | 2022 | |
| Genentech USA, INC. | $13.07 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.65 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.36 | 2022 | |
| Agile Therapeutics, INC. | $11.90 | 2022 | |
| Biogen, INC. | $11.12 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Larkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.